Karyotypic abnormalities in myelofibrosis following polycythemia vera

Cancer Genetics and Cytogenetics

Volumn 140, Issue 2, 2003, Pages 118-123

  Andrieux, Joris ^a,b   Demory, Jean Loup ^c   Caulier, Marie Thérèse ^e   Agape, Philippe ^d   Wetterwald, Marc ^d   Bauters, Francis ^e   Laï, Jean Luc ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Institut de Recherche sur le Cancer de Lille   (France)

^c Laboratoire d'Hématologie   (France)

^d Service d'Hématologie Clínique   (France)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHROMOSOME 13Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DELETION 13; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; HUMAN; ISOCHROMOSOME; KARYOTYPING; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; POSTPOLYCYTHEMIC MYELOFIBROSIS; PRIORITY JOURNAL; TETRASOMY; TRISOMY;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOMES, HUMAN; DISEASE PROGRESSION; FEMALE; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; MYELOFIBROSIS; MYELOID METAPLASIA; POLYCYTHEMIA VERA; SURVIVAL ANALYSIS;

EID: 0037439017     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00678-7     Document Type: Article

References (18)

1. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 342:2000;1255-1265.
2. Ellis J.T., Peterson P., Geller S.A., Rappaport H. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Semin Hematol. 23(2):1986;144-155.
3. Miller J.B., Testa J.R., Lindgren V., Rowley J.D. The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis. Cancer. 55(3):1985;582-591.
4. Rege-Cambrin G., Mecucci C., Tricot G., Michaux J.L., Louwagie A., Van Hove W., Francart H., Van den Berghe H. A chromosomal profile of polycythemia vera. Cancer Genet Cytogenet. 25(2):1987;233-245.
5. Swolin B., Weinfeld A., Westin J. A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood. 72(2):1988;386-395.
6. Aatola M., Armstrong E., Teerenhovi L., Borgstrom G.H. Clinical significance of the del(20q) chromosome in hematologic disorders. Cancer Genet Cytogenet. 62(1):1992;75-80.
7. Diez-Martin J.L., Graham D.L., Petitt R.M., Dewald G.W. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc. 66:1991;287-299.
8. Demory J.L., Dupriez B., Fenaux P., Laï J.L., Beuscart R., Bauters F. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia. Blood. 72:1988;855-859.
9. Reilly J.T., Snowden J.A., Spearing R.L., Fitzgerald P.M., Jones N., Watmore A., Potter A. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis. a study of 106 cases Br J Haematol. 98:1997;96-102.
10. Tefferi A., Mesa R.A., Schroeder G., Hanson C.A., Li C.Y., Dewald G.W. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia. Br J Haematol. 113:2001;763-771.
11. Merlat A., Laï J.L., Sterkers Y., Demory J.L., Bauters F., Preudhomme C., Fenaux P. Therapy related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases. Leukemia. 13(2):1999;250-257.
12. Berk P.D., Goldberg J.D., Donovan P.B., Fruchtman S.M., Berlin N.I., Wasserman L.R. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol. 23(2):1986;132-143.
13. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel.
14. Dupriez B., Morel P., Demory J.L., Laï J.L., Simon M., Plantier I., Bauters F. Prognostic factors in agnogenic myeloid leukemia. a report on 195 cases with a new scoring system Blood. 88:1996;1013-1018.
15. Sterckers Y., Preudhomme C., Laï J.L., Demory J.L., Caulier M.T., Wattel E., Bordessoule D., Bauters F., Fenaux F. Acute myeloid leukemia and myelodysplastic syndrome following essential thrombocythemia. high proportion of cases with 17p deletion Blood. 91:1998;616-622.
16. Davidovitz Y., Lev D., Ballin A., Tsudik A., Meytes D. Translocation (1;20)(q32;q13.3) in myelofibrosis following polycythemia vera. Cancer Genet Cytogenet. 101:1998;156-158.
17. Michaux L., Dierlamm J., Mecucci C., Meeus P., Ameye G., Libouton J.M., Verhoef G., Ferrant A., Louwagie A., Verellen-Dumoulin C., Van den Berghe H. Dicentric (1;15) in myeloid disorders. Cancer Genet Cytogenet. 88:1996;86-89.
18. Randi M.L., Barbone E., Fabris F., Varotto L., Macri C., Girolami A. Post-polycythemia myeloid metaplasia. experience with a large cohort of patients J Med. 25(6):1994;363-369.